ASPECT BIOSYSTEMS LTD.

Products

Category Product Brand Description
Current Bioprinting Prospects and Future Innovations (BIO176B)
Bioprinted Tissue Therapeutics (BTTs)
Aspect Biosystems develops functional and immune-protective tissues intended to enhance, restore, or replace biological processes within the body.
Diabetes and Obesity Program
Aspect Biosystems is engaged in developing bioprinted tissues for treating diabetes and metabolic disorders in partnership with other companies.
Adrenal Tissue Program
It is working on developing BTTs to restore adrenal function and treat primary adrenal insufficiency.

This information is available for BCC Research members only.

AI Sentiment